About Novocardia
Novocardia is a Healthcare company based in New York (United States) founded in 2020. Novocardia has raised $53.7 million across 1 funding round from investors including Deerfield. Novocardia offers products and services including Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program. Its focus areas include Clinic Chains, Specialty Clinics and Cardiology. Its legal entity is Cardiovascular Associates of America. Its competitors include HeartPlace, National Cardiovascular Partners and Cardiovascular Institute of Central Florida.
Company details
Novocardia was founded in 2020 in New York, United States, within the healthcare sector focused on cardiovascular services. Value-based care models are developed and implemented to address heart failure management, site-of-service optimization, and care transition interventions. Technology and analytics are employed to support care coordination, reduce hospitalizations, and enhance operational efficiency. Partnerships with physicians and payers are established across the United States to facilitate better patient outcomes at reduced costs.
- Headquarters New York, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website novocardiahealth.com
- Social LinkedIn X Facebook
- Legal Name Cardiovascular Associates Of America
- Total Equity Funding$53.7M (USD)
in 1 rounds
- Latest Funding Round$53.7M (USD), Series A
Jun 2021
- Investors
Products & Services of Novocardia
Novocardia offers a comprehensive portfolio of products and services, including Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program.
Supports heart failure patients with monitoring and self-management to prevent hospitalizations.
Manages locations for cost-effective imaging and procedures while maintaining quality.
Facilitates smooth transitions between care settings to reduce unnecessary visits.
Provides prompt specialist appointments for timely cardiovascular care delivery.
Funding Insights of Novocardia
Novocardia has successfully raised a total of $53.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $53.7 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.7M
- Total Rounds 1
- Last Round Series A — $53.7M
- First Round $53.7M
(Jun 2021)
- Investors Count 1
All 1 funding rounds of Novocardia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $53.7M | Series A | – | Deerfield | – |
1 investors in total: 1 institutional.
Investors in Novocardia
Novocardia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States |
Investor details for Novocardia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novocardia
12 people are tracked at Novocardia (5 in leadership, 7 in board & advisors).
| Name | Role | Group |
|---|---|---|
Kathryn Hughes | Acting Chief Marketing Officer | Leadership |
Michael Petit | CFO & COO, Traditional Practice Management Services | Leadership |
Julius Torelli | Co-Founder & Chief Medical Officer | Leadership |
Brian Richards | VP, IT & Business Systems | Leadership |
Jesse VanGeison | VP, Central Operations & Integration | Leadership |
Harry Aldrich | Director | Board & advisors |
David J. Jacofsky | Director | Board & advisors |
Dinesh Pubbi | Director | Board & advisors |
Steve Anastos | Director | Board & advisors |
Hoangmai Pham | Scientific Advisor | Board & advisors |
Michael R. Jaff | Director | Board & advisors |
Gaurov Dayal | Scientific Advisor | Board & advisors |
Complete people profiles for Novocardia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Novocardia
2 dated milestones of Novocardia across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Novocardia is founded.
- Funding First funding round of $53.7M.
Competitors of Novocardia
Novocardia has 3 listed competitors in our database. They include HeartPlace, National Cardiovascular Partners and Cardiovascular Institute of Central Florida.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heartplace.com | 1961 | Dallas, United States | A chain of cardiology clinics is operated nationwide. | |||
| ncplp.com | 2004 | Houston, United States | Chain of general clinics | |||
| cvicfl.com | 2006 | Ocala, United States | 104 | Offers cardiology care including diagnosis and treatment of heart conditions. |
Detailed competitors of Novocardia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Novocardia
The website of Novocardia (novocardiahealth.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 11.6% vs previous month
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Novocardia (Hospitals & Clinical Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Multi-specialty hospitals and surgery centers are operated nationwide. | 1968 | Nashville, Tennessee, United States | USD 97.27 M | USD 75.6 B | 316,000 | |
Standalone veterinary clinics are operated for pet care services. | 2017 | New York, New York, United States | USD 98.5 M | |||
Healthcare services, research, education, and community support are provided. | 1942 | United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novocardia
Complete news archive for Novocardia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novocardia
Novocardia was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Novocardia is headquartered in New York, United States. It is registered at New York, New York, United States.
Novocardia is a funded company, having raised a total of $53.7M across 1 funding round to date. The company's 1st funding round was a Series A of $53.7M, raised on Jun 2021.
Novocardia was founded in 2020 in New York, United States, within the healthcare sector focused on cardiovascular services. Value-based care models are developed and implemented to address heart failure management, site-of-service optimization, and care transition interventions. Technology and analytics are employed to support care coordination, reduce hospitalizations, and enhance operational efficiency. Partnerships with physicians and payers are established across the United States to facilitate better patient outcomes at reduced costs.
Novocardia's top competitors include National Cardiovascular Partners, HeartPlace and Cardiovascular Institute of Central Florida.
Novocardia offers Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program.
Novocardia has 1 investor. Key investors include Deerfield.
Novocardia operates through Cardiovascular Associates Of America.